TapImmune Inc (OTCQB:TPIV)

Data as of Jan 30
 +0.002 / +1.11%
Today’s Change
Today|||52-Week Range
Consumer Services
Other Consumer Services

Company Description

TapImmune, Inc. is a clinical-stage immunotherapy company, which specializes in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and infectious disease. The Company combines a set of proprietary technologies to improve the ability of the cellular immune system to destroy diseased cells. It also provides treatment for other vaccine technologies that narrowly address the initiation of an immune response, TapImmune's approach broadly stimulates the cellular immune system by enhancing the function of killer T-cells and T-helper cells and by restoring antigen presentation in tumor cells allowing their recognition and killing by the immune system. TapImmune was founded in 1991 and is headquartered in Seattle, Washington.

Contact Information

TapImmune, Inc.
1551 Eastlake Avenue East
Seattle Washington 98102
P:(206) 504-7278
Investor Relations:
(206) 504-7267



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Glynn WilsonChairman, CEO, CFO, Secretary & CAO
Robert Z. FlorkiewiczSenior Director-Molecular Biology & Head-Research
Mark ReddishDirector & Vice President-Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.